Exact Mass: 546.1026
Exact Mass Matches: 546.1026
Found 33 metabolites which its exact mass value is equals to given mass value 546.1026,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ceftazidime
Ceftazidime is only found in individuals that have used or taken this drug. It is a semisynthetic, broad-spectrum antibacterial derived from cephaloridine and used especially for Pseudomonas and other gram-negative infections in debilitated patients. [PubChem]The bactericidal activity of ceftazidime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
dTDP-L-mycarose
A dTDP-sugar having beta-L-mycarose as the sugar component.
alpha-D-Galactopyranuronosyl-(1->4)-alpha-D-galactopyranuronosyl-(1->4)-D-galacturonic acid
alpha-D-Galactopyranuronosyl-(1->4)-alpha-D-galactopyranuronosyl-(1->4)-D-galacturonic acid is isolated from enzymic hydrolysates (yeast or mould pectinases) of pectic acid. Also from partial acid hydrolysis of Medicago sativa (lucerne) pectin. Isolated from enzymic hydrolysates (yeast or mould pectinases) of pectic acidand is) also from partial acid hydrolysis of Medicago sativa (lucerne) pectin
Ceftazidime anhydrous
4-O-methylellagic acid 3-(2,3-di-O-acetyl)-alpha-L-rhamnoside|4-O-Methylellagic acid 3-(2,3-di-O-acetyl)-??-L-rhamnoside|4-O-methylellagic acid 3-(2,3-di-O-acetyl)-3-alpha-rhamnoside
4xi,5xi-di(3,4-dihydroxy-(E)-cinnamoyl)-2,6xi-dihydroxyhept-2-en-1,7-dioic acid
rhein-8-O-beta-D-[6-O-(3-methoxymalonyl)]glucopyranoside
Pectic acid
Ceftazidime
A cephalosporin bearing pyridinium-1-ylmethyl and {[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams CONFIDENCE standard compound; EAWAG_UCHEM_ID 3238
Trigalacturonic acid
1-[[(6R,7R)-7-[[(2E)-(2-Amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-pyridinium inner salt
[4-({4-(6-Methoxy-3-pyridinyl)-5-[4-(trifluoromethoxy)phenyl]-1,3 -thiazol-2-yl}methoxy)-2-methylphenoxy]acetic acid
β-D-Mannopyranuronic acid
Alginic acid is a natural polysaccharide, which has been widely concerned and applied due to its excellent water solubility, film formation, biodegradability and biocompatibility. Alginic acid induces oxidative stress-mediated hormone secretion disorder, apoptosis and autophagy in mouse granulosa cells and ovaries. Alginic acid has an inhibitory effect on histamine release. Anti-anaphylactic and anti-inflammatory properties[1][2][3]. Alginic acid is a natural polysaccharide, which has been widely concerned and applied due to its excellent water solubility, film formation, biodegradability and biocompatibility. Alginic acid induces oxidative stress-mediated hormone secretion disorder, apoptosis and autophagy in mouse granulosa cells and ovaries. Alginic acid has an inhibitory effect on histamine release. Anti-anaphylactic and anti-inflammatory properties[1][2][3].
alpha-D-GalpA-(1->4)-alpha-D-GalpA-(1->4)-alpha-D-GalpA
A trisaccharide in which three alpha-D-galactopyranuronic acid units are joined via (1->4)-linkages.
7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Rhythmy
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives
1-{[(6R,7R)-2-carboxy-7-[(2Z)-2-[(1-carboxylato-1-methylethoxy)imino]-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium
4'-o-methylellagicacid 3-(2'',3''-di-o-acetyl)-α-l-rhamnoside
{"Ingredient_id": "HBIN010778","Ingredient_name": "4'-o-methylellagicacid 3-(2'',3''-di-o-acetyl)-\u03b1-l-rhamnoside","Alias": "NA","Ingredient_formula": "C25H22O14","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14335","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
